In addition, AURKA itself has been shown to be a target gene of both MAPK1/ERK2 signalling in pancreatic cancer cells22 and Wnt/β-catenin signalling in multiple myeloma23. The gene discussed is AURKA; the disease is familial pancreatic carcinoma.